Weinshenker BG - Search Results

1

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Jacob A, et al. Among authors: weinshenker bg. Arch Neurol. 2008 Nov;65(11):1443-8. doi: 10.1001/archneur.65.11.noc80069. Epub 2008 Sep 8. Arch Neurol. 2008. PMID: 18779415

2

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS.

Weinshenker BG, Issa M, Baskerville J. Weinshenker BG, et al. Neurology. 1996 Jun;46(6):1613-9. doi: 10.1212/wnl.46.6.1613. Neurology. 1996. PMID: 8649559

3

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study.

Weinshenker BG, Issa M, Baskerville J. Weinshenker BG, et al. Arch Neurol. 1996 Apr;53(4):353-8. doi: 10.1001/archneur.1996.00550040093018. Arch Neurol. 1996. PMID: 8929158

4

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.

Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS. Weinshenker BG, et al. Neurology. 1997 Aug;49(2):378-85. doi: 10.1212/wnl.49.2.378. Neurology. 1997. PMID: 9270565

5

A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.

Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG. Wingerchuk D, et al. Among authors: weinshenker bg. Neurology. 1997 Aug;49(2):626-8. doi: 10.1212/wnl.49.2.626. Neurology. 1997. PMID: 9270614

6

Clinical outcome measures and rating scales in multiple sclerosis trials.

Wingerchuk DM, Noseworthy JH, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Mayo Clin Proc. 1997 Nov;72(11):1070-9. doi: 10.4065/72.11.1070. Mayo Clin Proc. 1997. PMID: 9374984 Review.

7

Denaturation fingerprinting: two related mutation detection methods especially advantageous for high G + C regions.

Liu Q, Weinshenker BG, Wingerchuk DM, Sommer SS. Liu Q, et al. Among authors: weinshenker bg. Biotechniques. 1998 Jan;24(1):140-7. doi: 10.2144/98241rr01. Biotechniques. 1998. PMID: 9454966 Free article.

8

Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS.

Weinshenker BG, Hebrink D, Wingerchuk DM, Klein CJ, Atkinson E, O'Brien PC, McMurray CT. Weinshenker BG, et al. Neurology. 1999 Apr 22;52(7):1500-3. doi: 10.1212/wnl.52.7.1500. Neurology. 1999. PMID: 10227645

9

The clinical course of neuromyelitis optica (Devic's syndrome).

Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Neurology. 1999 Sep 22;53(5):1107-14. doi: 10.1212/wnl.53.5.1107. Neurology. 1999. PMID: 10496275

10

The natural history of multiple sclerosis: implications for trial design.

Wingerchuk DM, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Curr Opin Neurol. 1999 Jun;12(3):345-9. doi: 10.1097/00019052-199906000-00013. Curr Opin Neurol. 1999. PMID: 10499179 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters